|1.||Hu, Die: 1 article (06/2014)|
|2.||Wu, Tangchun: 1 article (06/2014)|
|3.||Guo, Huan: 1 article (06/2014)|
|4.||Deng, Siyun: 1 article (06/2014)|
|5.||Li, Jun: 1 article (06/2014)|
|6.||Zhu, Xiaoyan: 1 article (06/2014)|
|7.||Deng, Qifei: 1 article (06/2014)|
|8.||Xu, Xiaohui: 1 article (09/2013)|
|9.||Sheps, David S: 1 article (09/2013)|
|10.||Kearney, Gregory D: 1 article (09/2013)|
06/01/2014 - "After adjustment for confounding factors and using the 1st quartile of 1-hydroxyphenanthrene as a reference, the odds ratio for hyperuricemia in subjects with the 2nd, 3rd, and 4th quartiles of 1-hydroxyphenanthrene were 1.55, 1.57, and 2.35, respectively. "
06/01/2014 - "Urinary 1-hydroxyphenanthrene is associated with a dose-response increase in serum uric acid levels in coke oven workers, and exposure to phenanthrene in PAHs may be a risk factor for hyperuricemia."
09/01/2013 - "In a logistic regression model, subjects within the middle and highest tertiles of fluorene metabolites, 2-hydroxyfluorene (2-FLUO) and 3-hydroxyfluorene (3-FLUO), and phenanthrene metabolites, 1-hydroxyphenanthrene (1-PHEN) and 2-hydroxyphenanthrene (2-PHEN), had significantly higher prevalence of PAD as compared to subjects within the lowest tertile after adjusting for cigarette smoking, diabetes mellitus and other covariates (For 2-FLUO, the 3rd tertile: OR=2.22, 95% CI=1.13-4.37, p for trend=0.02; For 3-FLUO, the 3rd tertile: OR=2.36, 95% CI: 1.16-4.77, p for trend=0.02; For 1-PHEN, the 3rd tertile: OR=1.84, 95% CI: 1.01-3.37, p for trend=0.04; For 2-PHEN, the 3rd tertile: OR=1.76, 95% CI: 1.07-2.88, p for trend=0.03). "
|2.||Uric Acid (Urate)